The WHO new Essential Diagnostics List (EDL) aims to provide a structure for identifying, promoting, and increasing the supply and availability of the most effective and important in-vitro diagnostics. If the EDL is to be useful to health policy planners, however, use of appropriate coding systems should also be an early consideration.